CN1559572A - Compound Sanhuang powder - Google Patents

Compound Sanhuang powder Download PDF

Info

Publication number
CN1559572A
CN1559572A CNA2004100219759A CN200410021975A CN1559572A CN 1559572 A CN1559572 A CN 1559572A CN A2004100219759 A CNA2004100219759 A CN A2004100219759A CN 200410021975 A CN200410021975 A CN 200410021975A CN 1559572 A CN1559572 A CN 1559572A
Authority
CN
China
Prior art keywords
radix
herba
prescription
sanhuangsan
cordyceps
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CNA2004100219759A
Other languages
Chinese (zh)
Other versions
CN1234408C (en
Inventor
陈大刚
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 200410021975 priority Critical patent/CN1234408C/en
Publication of CN1559572A publication Critical patent/CN1559572A/en
Application granted granted Critical
Publication of CN1234408C publication Critical patent/CN1234408C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Abstract

A Chinese medicine for treating AIDS and cancers and suppressing HIV, cancer cell, and DNA (or RNA) viruses is prepared from 16 Chinese-medicinal materials including astragalus root, liquorice root, Chinese angelica root, cordyceps, etc.

Description

Complex prescription SANHUANGSAN
Technical field
The present invention is a kind of treatment acquired immune deficiency syndrome (AIDS) and anti-cancer drug preparation with the crude drug preparation.
Background technology
Acquired immune deficiency syndrome (AIDS) comprises that AIDSinfected patient and all kinds of malignant tumor, cancer are the diseases of serious threat human health.Still the specific drug that does not have at present the treatment acquired immune deficiency syndrome (AIDS); The main means that are used for the treatment of cancer are chemotherapy, the chemotherapeutics overwhelming majority of clinical practice makes toxic and side effects such as the patient feels sick, vomiting, leukopenia, bone marrow depression, influence patient's body health, also limited the clinical practice of chemotherapeutics greatly.Therefore, seek high activity, nontoxic or hypotoxic pure natural treatment acquired immune deficiency syndrome (AIDS) and cancer therapy drug become an important topic of new drug research.
Summary of the invention
The invention provides a kind of complex prescription SANHUANGSAN, has eliminating toxic substances to remove stasis, set upright and get rid of evils, strengthen the effect of immune function of human body, be to be applicable to aids patient, comprise AIDSinfected patient and all kinds of cancer patient, suppress HIV, malignant cell and other DNA, RNA viruses, the medicine preparation of promote people body immunity function.
Pure Chinese medicinal preparation provided by the invention shows through pharmacodynamics and clinical observation treatment effect: a, it has inhibitory action to HIV, malignant cell; B, it has obvious potentiation to animal and immune function of human body.It is by environment in improvement, adjusting and the balance body system, promote body system performance " creation certainly ", " selfreparing ", " self-regulation ", " defence certainly ", " self-organizing " behavior and be tending towards perfect in mesomeric mode on the whole, thereby resist and treat above-mentioned disease.
Complex prescription SANHUANGSAN provided by the invention is made by following method: Cortex Phellodendri 18g~20.9g, Radix Astragali 28g~33g, Radix Scutellariae 28g~32g, Semen Cuscutae 28g~33g, Rhizoma Atractylodis Macrocephalae 19g~25g, Herba Hedyotidis Diffusae 30g~45g, Radix Pulsatillae 25g~30g, Radix Bupleuri 15g~18g, Herba Taraxaci 16g~21g, Radix Saposhnikoviae 25g~30g, Radix Glycyrrhizae 16g~19g, Radix Angelicae Sinensis 28g~34g, Cordyceps 37g~46g, Rhizoma Curcumae 19g~23g, Cortex Moutan 17g~22g, Herba Violae 27g~32g amount to 16 flavors
A, the Cortex Phellodendri with in the above prescription, the Radix Astragali, Radix Scutellariae, Semen Cuscutae, the Rhizoma Atractylodis Macrocephalae, Radix Angelicae Sinensis, Herba Violae 7 flavors add water and are warming up to 100 degree water and carry 1 hour behind the selecting crude drugs with winnower decontamination, continuous three extraction backs with the dried paste of extracting liquid filtering simmer down to, are chilled to room temperature and pulverize under 20 ℃;
B, the Herba Hedyotidis Diffusae with in the above prescription, the Radix Pulsatillae, Radix Bupleuri, Herba Taraxaci, Radix Saposhnikoviae, Radix Glycyrrhizae, Cordyceps, Rhizoma Curcumae, Cortex Moutan 9 flavors are made the meticulous powder of 4~10 μ m behind the ultra micro breaking cellular wall, manufactured goods keep moisture 4~9%;
C, two steps of a, b are made thing mix and add 0.4~1.5 times of pharmaceutic adjuvant, evenly stir and make granule dosage form or capsule after vacuum spray drying is handled.
Described preparation method can adopt supersonic speed four-way molecule head-on collision technology to carry out production and processing, concrete manufacture technology link is: coarse pulverization, the sieve that shakes, selecting crude drugs with winnower, ultra-fine, breaking cellular wall, ultra micro, handle through this kind ultramicrotechnique, drug cell molecule breaking cellular wall, diameter of aspirin particle is 5 μ m~10 μ m, and manufactured goods keep moisture 4~9%.
Described best proportioning is: Cortex Phellodendri 20.9g, Radix Astragali 33g, Radix Scutellariae 31.9g, Semen Cuscutae 33g, Rhizoma Atractylodis Macrocephalae 24.2g, Herba Hedyotidis Diffusae 39.6g, Radix Pulsatillae 28.6g, Radix Bupleuri 17.6g, Herba Taraxaci 19.8g, Radix Saposhnikoviae 28.6g, Radix Glycyrrhizae 17.6g, Radix Angelicae Sinensis 33g, Cordyceps 44g, Rhizoma Curcumae 22g, Cortex Moutan 19.8g, Herba Violae 30.8g.
Above-mentioned peroral dosage form can be granule, capsule, tablet or syrup, oral liquid.
Above-mentioned 16 flavor Chinese crude drugs, net weight 444.4 grams, every flavor is prepared with 6~18 times of dose-effect relationships, adds medical accessory and makes 1000 bags of granule dosage forms or 1000 seed lac wafers.
The specific embodiment:
1. complex prescription SANHUANGSAN granule therapy acquired immune deficiency syndrome (AIDS) and AIDS related complex 11 examples.Wherein 7 routine remissions, 4 routine HIV carrying capacity decline 〉=0.5Log, 3 routine CD4+T lymphocytes rise 〉=20%, effective percentage 63.63%.
2. carry out the human body phase ii clinical trial in the somewhere, Yunnan, with complex prescription SANHUANGSAN granule therapy acquired immune deficiency syndrome (AIDS) (AIDS) and AIDS related complex (ARC) 41 examples, matched group 39 examples are used placebo, and two groups all give Western medicine symptomatic treatment and nutritional support.Before the treatment, through asking treasure, health check-up, conventional blood cell analysis, hepatic and renal function inspection, CD3+CD4+CD8+T lymphocyte count (flow cytometry), HIV carrying capacity mensuration<test kit: AMPLICOR HIV-IMONNITOR TM Test Version1.5 (Roche Diagnostics, Branchburg, NJ08876 USA)>, checks such as X line rabat, B ultrasonic and electrocardiogram, find that some cases clinical symptom disappearance or obviously improvements, spiritual appetite improvement, weight increase, opportunistic infection control; Lymphocyte absolute counting, CD4+T lymphocyte rising 〉=20%, HIV carrying capacity decline 〉=0.5Log.Treatment group effective percentage 63.42% is compared with matched group, and obvious significant difference P<0.05 is arranged.
After the drug withdrawal 5 months, organize among the 41 routine patients, taken out 20 example checks at random, 〉=25% 6 examples of CD4+T lymphocyte rising as a result, HIV carrying capacity decline 〉=0.5Log person 5 examples, HIV carrying capacity decline 〉=0.4-0.49Log person 3 examples in treatment.Drug withdrawal still kept 56.58% effective percentage in 5 months.

Claims (5)

1, complex prescription SANHUANGSAN, it is characterized in that being made by following method: Cortex Phellodendri 18g~20.9g, Radix Astragali 28g~33g, Radix Scutellariae 28g~32g, Semen Cuscutae 28g~33g, Rhizoma Atractylodis Macrocephalae 19g~25g, Herba Hedyotidis Diffusae 30g~45g, Radix Pulsatillae 25g~30g, Radix Bupleuri 15g~18g, Herba Taraxaci 16g~21g, Radix Saposhnikoviae 25g~30g, Radix Glycyrrhizae 16g~19g, Radix Angelicae Sinensis 28g~34g, Cordyceps 37g~46g, Rhizoma Curcumae 19g~23g, Cortex Moutan 17g~22g, Herba Violae 27g~32g amount to 16 flavors
A, the Cortex Phellodendri with in the above prescription, the Radix Astragali, Radix Scutellariae, Semen Cuscutae, the Rhizoma Atractylodis Macrocephalae, Radix Angelicae Sinensis, Herba Violae 7 flavors add water and are warming up to 100 degree water and carry 1 hour behind the selecting crude drugs with winnower decontamination, after continuous three extractions, under 20 ℃,, be chilled to room temperature and pulverize the dried paste of extracting liquid filtering simmer down to;
B, the Herba Hedyotidis Diffusae with in the above prescription, the Radix Pulsatillae, Radix Bupleuri, Herba Taraxaci, Radix Saposhnikoviae, Radix Glycyrrhizae, Cordyceps, Rhizoma Curcumae, Cortex Moutan 9 flavors are made the meticulous powder of 4~10 μ m behind the ultra micro breaking cellular wall, manufactured goods keep moisture 4~9%;
C, two steps of a, b are made thing mix and add 0.4~1.5 times of pharmaceutic adjuvant, evenly stir and make granule dosage form or capsule after vacuum spray drying is handled.
2, complex prescription SANHUANGSAN according to claim 1, it is characterized in that adopting supersonic speed four-way molecule head-on collision technology to carry out production and processing, concrete manufacture technology link is: coarse pulverization, the sieve that shakes, selecting crude drugs with winnower, ultra-fine, breaking cellular wall, ultra micro, handle through this kind ultramicrotechnique, drug cell molecule breaking cellular wall, diameter of aspirin particle is 5 μ m~10 μ m, and manufactured goods keep moisture 4~9%.
3, complex prescription SANHUANGSAN according to claim 1 is characterized in that best proportioning is: Cortex Phellodendri 20.9g, Radix Astragali 33g, Radix Scutellariae 31.9g, Semen Cuscutae 33g, Rhizoma Atractylodis Macrocephalae 24.2g, Herba Hedyotidis Diffusae 39.6g, Radix Pulsatillae 28.6g, Radix Bupleuri 17.6g, Herba Taraxaci 19.8g, Radix Saposhnikoviae 28.6g, Radix Glycyrrhizae 17.6g, Radix Angelicae Sinensis 33g, Cordyceps 44g, Rhizoma Curcumae 22g, Cortex Moutan 19.8g, Herba Violae 30.8g.
4, complex prescription SANHUANGSAN according to claim 1 is characterized in that: above-mentioned peroral dosage form can be granule, capsule, tablet or syrup, oral liquid.
5, according to claim 1 and 3 described complex prescription SANHUANGSANs, it is characterized in that: above-mentioned 16 flavor Chinese crude drugs, net weight 444.4 grams, every flavor is prepared with 6~18 times of dose-effect relationships, adds medical accessory and makes 1000 bags of granule dosage forms or 1000 seed lac wafers.
CN 200410021975 2004-03-05 2004-03-05 Compound Sanhuang powder Expired - Fee Related CN1234408C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 200410021975 CN1234408C (en) 2004-03-05 2004-03-05 Compound Sanhuang powder

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 200410021975 CN1234408C (en) 2004-03-05 2004-03-05 Compound Sanhuang powder

Publications (2)

Publication Number Publication Date
CN1559572A true CN1559572A (en) 2005-01-05
CN1234408C CN1234408C (en) 2006-01-04

Family

ID=34440954

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 200410021975 Expired - Fee Related CN1234408C (en) 2004-03-05 2004-03-05 Compound Sanhuang powder

Country Status (1)

Country Link
CN (1) CN1234408C (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101129493B (en) * 2007-08-17 2010-09-22 天津中天制药有限公司 Antineoplastic anti-AIDS pharmaceutical composition and method of preparing the same
CN102614467A (en) * 2012-04-19 2012-08-01 钟波 Traditional Chinese medical composition for treatment of acquired immunodeficiency syndrome and preparation method and application thereof
CN104721702A (en) * 2015-04-09 2015-06-24 山东省立医院 Traditional Chinese medicine for treating colorectal cancer
CN107259627A (en) * 2017-06-22 2017-10-20 黄斌华 Integration of drinking and medicinal herbs nano micromolecule and its preparation technology and integration of drinking and medicinal herbs food

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101129493B (en) * 2007-08-17 2010-09-22 天津中天制药有限公司 Antineoplastic anti-AIDS pharmaceutical composition and method of preparing the same
CN102614467A (en) * 2012-04-19 2012-08-01 钟波 Traditional Chinese medical composition for treatment of acquired immunodeficiency syndrome and preparation method and application thereof
CN104721702A (en) * 2015-04-09 2015-06-24 山东省立医院 Traditional Chinese medicine for treating colorectal cancer
CN107259627A (en) * 2017-06-22 2017-10-20 黄斌华 Integration of drinking and medicinal herbs nano micromolecule and its preparation technology and integration of drinking and medicinal herbs food

Also Published As

Publication number Publication date
CN1234408C (en) 2006-01-04

Similar Documents

Publication Publication Date Title
CN1094055C (en) Medicine for curing common cold and cough and its preparing process
CN105362340B (en) A kind of pharmaceutical composition for treating leukaemia and preparation method thereof
CN102114099B (en) Traditional Chinese medicine preparation for inhibiting liver cancer and preparation method thereof
CN101711848B (en) Chinese medicinal composition capable of adjunctively treating tumour
CN102319357B (en) Lipid-lowering dispersible tablets and preparation technology thereof
CN1234408C (en) Compound Sanhuang powder
CN102657736B (en) Medicament composition for treating rheumatoid arthritis and preparation method of medicament composition
CN1330359C (en) Chinese medicine preparation for treating AIDS and process thereof
CN1329060C (en) Combination of medication for treating hepatic disease, preparation method and application
CN102805810B (en) Chinese medicinal preparation for treating acquired immune deficiency syndrome (AIDS) and preparation method thereof
CN102526613B (en) Medicament for treating allergic cutaneous vasculitis
CN101966239B (en) Chinese medicinal composition for preventing and treating cardiac cerebral and vascular diseases and preparation method thereof
CN101695562A (en) Chinese medicinal composition for treating viral hepatitis and preparation method thereof
CN101244186A (en) Medicine preparation for treating hepatitis B, and method of preparing the same
CN1313118C (en) Method for preparing Chinese medicine rapid-release concentrated pill for treating mammary gland poliferation
CN1899574A (en) Chinese medicine composition for preventing and controlling liver cancer and its use
CN102670831B (en) Medicinal composition for treating dermatomyositis and preparation method thereof
CN1194756C (en) Oral Chinese medicinal contraceptive medicine
CN115487260B (en) Traditional Chinese medicine composition for treating hypercholesterolemia or atherosclerosis and application thereof
CN102614467A (en) Traditional Chinese medical composition for treatment of acquired immunodeficiency syndrome and preparation method and application thereof
CN102406869B (en) Intestine-protecting and detoxifying micro pellets and use thereof
CN101757283B (en) Traditional Chinese medicine composition pill for treating gastrointestinal diseases and preparation method thereof
CN1981812B (en) Chinese-medicinal preparation for treating AIDS and its production
CN1208630A (en) Traditional Chinese medicine series used for anticancer and method for preparing same
CN1478520A (en) Heat-clearing and detoxic medicine and its preparation method

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20060104